Introduction {#s0005}
============

According to the World Health Organization (WHO), the most significant effects of climate change on human health will be driven by infectious diseases and undernutrition ([@b0165]). Climate variables affect all components of every ecosystem ([Table 1](#t0005){ref-type="table"} ). In the biomedical paradigm, this includes all microorganisms (beneficial and pathogenic, opportunistic and indifferent) that are involved in human health and affairs. The geographic expansion of microbes and vectors into new territories, made possible by sustained warmer temperatures at higher latitudes and increased human travel, exposes all planetary life to diseases previously unknown in particular habitats. More frequent extreme weather events (EWEs; [@b0285]), including heat waves, drought, and floods ([Table 2](#t0010){ref-type="table"} ), create circumstances where existing infectious microorganisms flourish and novel infections emerge. Furthermore, in many regions, the myriad consequences of climate change drive mass intranational and international human migration, which disturbs regional health care infrastructure and the habitats of microbes, vectors, and animal reservoirs.Table 1Essential climate variables.AtmosphereOceanLand*[Surface]{.ul}*•Precipitation•Pressure•Surface radiation budget•Surface wind speed/direction•Temperature•Water vapor*[Physics]{.ul}*•Ocean surface heat flux•Sea ice•Sea level•Sea state•Sea surface salinity•Sea surface temperature•Subsurface currents•Subsurface salinity•Subsurface temperature•Surface currents•Surface stress•Above-ground biomass•Albedo•Anthropogenic greenhouse gas fluxes•Anthropogenic water use•Fire•Fraction of absorbed photosynthetically active radiation•Glaciers•Groundwater•Ice sheets and ice shelves•Lakes•Land cover•Land surface temperature•Latent and sensible heat fluxes•Leaf area index•Permafrost•River discharge•Snow•Soil carbon•Soil moisture*[Upper atmosphere]{.ul}*•Earth radiation budget•Lightning•Temperature•Water vapor•Wind speed/direction*[Biogeochemistry]{.ul}*•Inorganic carbon•Nitrous oxide•Nutrients•Ocean color•Oxygen•Transient tracers*[Composition]{.ul}*•Aerosols properties•CO~2~, methane, other greenhouse gases•Cloud properties•Ozone*[Biology/ecosystems]{.ul}*•Marine habitat properties•Plankton[^1]Table 2Extreme weather events.Extreme weather eventsHeat wavesDroughtHeavy downpoursFloodsHurricanesWinter storms

Climate-sensitive infections have various transmission patterns ([Table 3](#t0015){ref-type="table"} ), including vector-borne, water-borne without requiring vectors, and human-to-human. Physicians who were trained or practice where these diseases are rare may find them challenging to recognize and diagnose. Herein, we review the effects of climate change on infectious diseases with dermatologic manifestations.Table 3Climate-sensitive infectious diseases with dermatologic manifestations.Mechanism of climate sensitivitySpecific disease examplesInfectious microbes are directly sensitive to climate variables (temperature, rainfall, humidity)[Viruses]{.ul}: Enteroviruses (Hand, foot, and mouth disease), Chikungunya, Zika\
[Bacteria]{.ul}: *Vibrio vulnificus* infection\
[Fungi]{.ul}: coccidioidomycosis  Enhanced survival and expanded geographic range of climate-sensitive vectors and animal reservoirs*[Aedes]{.ul}*[mosquito species]{.ul}: Chikungunya, Dengue, yellow fever, Zika, lymphatic filariasis,\
*[Anopheles]{.ul}*[mosquito species]{.ul}: Lymphatic filariasis\
*[Culex]{.ul}*[mosquito species]{.ul}: West Nile fever, lymphatic filariasis\
[Phlebotamine sandflies]{.ul}: Leishmaniasis variants\
[Ixodid (hard) ticks]{.ul}: Lyme disease and other borrelial infections, Rickettsial diseases (spotted fever, Q fever), Tularemia\
[Triatome bugs]{.ul}: Chagas disease (American trypanosomiasis)  Increased incidence during and after extreme weather events[Flooding]{.ul}: *Vibrio vulnificus* infection*, Mycobacterium marinum* infection, melioidosis (*Burkholderia pseudomallei* infection), leptospirosis, *Chromobacterium violaceum* infection, chromoblastomycosis, blastomycosis, mucormycosis, dermatophytosis, immersion foot syndromes (polymicrobial infection)\
[Drought]{.ul}: Coccidioidomycosis  Human migration, overcrowding, and poverty caused by climate change--related extreme weather eventsScabies infestation, body lice infestation (vector for epidemic typhus and louse-borne/epidemic relapsing fever), tuberculosis, human immunodeficiency virus, diarrheal diseases

Climate-sensitive vector-borne diseases {#s0010}
=======================================

Vector-borne diseases (VBDs) are infectious diseases transmitted by living organisms, most commonly blood-sucking arthropods such as mosquitoes, ticks, flies, and fleas ([Table 4](#t0020){ref-type="table"} ; [@b0050]). Globally, VBDs cause \>700,000 deaths annually ([@b0480]) and many lack vaccines, disease-specific treatments, or both. Over the last 150 years, major advances in public health, including sanitation, water supply safety, vector control, and vaccination, have driven a steady decline in the burden of VBDs. The overall prevalence of major, potentially life-threatening VBDs continued to decline from 2005 to 2015 ([@b0435]), likely due to improved health care infrastructure and declining severe poverty worldwide. However, climate change threatens these gains and, in some cases, may reverse disease-specific trends.Table 4Vector-borne diseases of human significance.VectorDisease causedType of pathogenMosquitoes*Aedes*Chikungunya\
Dengue\
Lymphatic filariasis\
Rift Valley fever\
Yellow fever\
ZikaVirus\
Virus\
Parasite\
Virus\
Virus\
Virus*Anopheles*Lymphatic filariasis\
MalariaParasite\
Parasite*Culex*Japanese encephalitis\
Lymphatic filariasis\
West Nile feverVirus\
Parasite\
Virus  Aquatic snailsSchistosomiasisParasite  BlackfliesOnchocerciasisParasite  FleasPlague\
TungiasisBacteria\
Ectoparasite  LiceTyphus\
Louse-borne relapsing feverBacteria\
Bacteria  SandfliesLeishmaniasis\
Sandfly feverBacteria\
Virus  TicksCrimean-Congo hemorrhagic fever\
Lyme disease\
Relapsing fever (borreliosis)\
Rickettsial diseases (spotted fever, Q fever)\
Tick-borne encephalitis\
TularemiaVirus\
Bacteria\
Bacteria\
Bacteria\
Virus\
Bacteria  Triatome bugsChagas disease (American trypanosomiasis)Parasite  Tsetse fliesSleeping sickness (African trypanosomiasis)Parasite[^2]

Climate variables affect the environmental suitability for VBD transmission in many ways. Warming promotes the expansion of geographic ranges of vector and reservoir populations, which establish themselves at higher latitudes and altitudes or across more seasons (i.e., during winter months when infections were previously rare). This is apparent in the increasing numbers of reported VBDs from arctic/subarctic regions, where warming is progressing more quickly and to a greater degree compared to lower latitudes ([@b0430]). Warmer temperatures often shorten the pathogen development time in vectors and quicken vector life cycles ([@b0150]) such that pathogen and vector populations may enter logarithmic growth. Changes in rainfall, including more frequent flooding, directly affect vectoral capacity (the efficiency with which vectors become infected with, carry, and transmit pathogens). Finally, environmental degradation, either manmade or due to EWEs, disrupts the habitats of disease vectors and animal reservoirs.

Mosquito-borne illnesses {#s0015}
------------------------

### Dengue {#s0020}

Dengue is a VBD caused by the dengue virus, a flavivirus transmitted to humans by *Aedes aegypti* and *Aedes albopictus* mosquitoes. As of 2019, approximately 3 billion people live in areas at risk for dengue, and an estimated 400 million dengue cases occur annually ([@b0470]). Only 25% of infected persons develop symptoms, typically a mild, self-limited febrile illness ([@b0470]). Facial flushing and blanching macular erythema with islands of sparing ([Fig. 1](#f0005){ref-type="fig"} ) may appear during the acute phase ([@b0470]). Rarely, severe and potentially fatal complications, including multisystem vascular leak syndrome and hemorrhagic disease, develop ([@b0470]). Persons previously infected with a different dengue serotype, children, and pregnant women (especially during the third trimester) have a higher risk for severe disease ([@b0470]).Fig. 1Dengue. Morbilliform eruption with islands of sparing due to acute Dengue.

No disease-specific treatments for dengue are available. The first dengue vaccine, CYD-TDV (Dengvaxia, SanofiPasteur), is a recombinant, live-attenuated tetravalent vaccine approved by the U.S. Food and Drug Administration in 2019 ([@b0420]). Its efficacy is influenced by viral serotype and host baseline serostatus. Seronegative individuals who receive the vaccine are more likely to develop severe disease with subsequent natural dengue infections ([@b0160]). The WHO now recommends incorporating antibody screening into vaccine campaigns so that only seropositive individuals are vaccinated ([@b0465]).

Although the incidence and mortality of other VBDs has declined recently, dengue-related mortality increased nearly 50% from 2005 to 2015 ([@b0435]). Moreover, in the past half-century, dengue's worldwide incidence increased 30-fold ([@b0050]). Approximately 75% of the global disease burden is in Asia ([@b0470]), and Southeast Asia experienced the largest increase in recent dengue-related mortality ([@b0445]). Indeed, dengue is now the leading cause of fever in travelers returning from Southeast Asia, surpassing malaria ([@b0360]). These trends reflect a steady worldwide increase in vectoral capacity for both dengue vectors ([@b0445]), which peaks near 29 °C ([@b0220]).

Traditionally confined to the tropics, dengue's geographic range is spreading because of warmer temperatures and increased human movement worldwide ([@b0220]). Since 2010, sporadic autochthonous transmission has been reported in new regions, including Croatia ([@b0145]), southern France ([@b0355]), Portugal ([@b0475]), and the southern United States (Florida, Texas, and North Carolina; [@b0075]). Currently, approximately 30 U.S. states are in the likely or very likely range of both mosquito vectors ([@b0085]). During this century, continued globalization and increasingly hospitable environments for *Aedes* spp. (due to global warming, forest destruction, disturbed urban and peri-urban environments, and human influence on land-use patterns) are projected to enable dengue's geographic range to continue expanding ([@b0220]). As the distribution of each serotype expands, more people are at risk for developing subsequent dengue infections, which are usually more severe; thus, the global burden of disease may increase substantially.

### Chikungunya {#s0025}

The chikungunya virus, a togavirus, is also transmitted by *Aedes* ([@b0270]). Most infected patients (72%-95%) develop acute-phase symptoms ([@b0390]), which include fever, severe symmetric polyarthralgias (typically fingers, wrists, elbows, knees, and ankles; [@b0390]), and a morbilliform exanthem ([@b0270]). Despite low mortality, chikungunya has substantial acute and chronic morbidity; 48% of persons develop postchikungunya chronic inflammatory rheumatism, typically 20 months later ([@b0485]). This causes economic losses, directly from health care costs and indirectly from impaired productivity ([@b0485]). Currently, there is no preventive vaccine or disease-specific treatment for chikungunya.

Chikungunya outbreaks are climate sensitive. They occur mainly in rainy seasons, when mosquito density is maximal, and are rare at altitudes \>2300 m ([@b0485]). The first modern outbreak of chikungunya occurred in Tanzania (then Tanganyika) in the late 1950s. Since then, globalization has facilitated viral spread. In 2007, a single infected traveler arriving from South Asia led to a 200-person outbreak in Italy ([@b0005]). The first endemic cases in the Caribbean occurred in December 2013 ([@b0270]). Since then, multiple cases occur annually in the United States, mostly in returning travelers, except for occasional autochthonous cases in Florida and Texas ([@b0090]). Global spread is partly due to an adaptive viral mutation that improved its transmissibility by *A. albopictus,* which survives at cooler temperatures than *A. aegypti* ([@b0450]).

### Zika {#s0030}

The Zika virus is another flavivirus transmitted by *Aedes* mosquitoes. Approximately 20% of infected persons are symptomatic ([@b0290]). Infection resembles mild dengue and may include fevers, rash, arthritis/arthralgia, and conjunctivitis ([@b0290]). Conjunctivitis (scleral erythema) may be more prominent with Zika than with other flavivirus infections ([@b0210]). Dermatologic manifestations include a morbilliform exanthem, erythematous acral macules and papules, and postillness palmar desquamation ([@b0290]). Zika first reached the Americas (Brazil) in 2015 ([@b0250]) and was soon implicated in causing devastating neurological effects, including agyria and microcephaly, in utero. The WHO declared a public health emergency of international concern. Zika virus transmission occurs at 22.7 °C to 34.7 °C and is maximal at 29 °C ([@b0395]). Worldwide, as more regions approach this temperature and more immunologically naïve persons are exposed, additional outbreaks are likely to occur.

### West Nile Virus {#s0035}

The West Nile Virus (WNV) is a flavivirus maintained in a bird--mosquito transmission cycle and has been identified in \>65 mosquito species and \>300 bird species in the United States alone ([@b0330]). However, only a few *Culex* species are competent at transmitting the virus to humans, who are typically dead-end viral hosts ([@b0330]). Clinical manifestations include an uncommon morbilliform rash, typically on days 5 to 12 of the illness, that affects the torso and extremities and spares the palms and soles ([@b0130], [@b0405]). No vaccines or disease-specific treatments are available.

WNV was introduced into the western hemisphere (New York) in 1999, spread to the Pacific Coast by 2003, and then to South America by 2005 ([@b0330]). WNV transmission is enhanced in warmer temperatures, which shorten the incubation time within mosquitoes and increase the efficiency of transmission to birds ([@b0205], [@b0345]). Outbreaks in Canada ([@b0140]), Israel ([@b0320]), and Russia ([@b0335]) correlate with periods of high temperatures. In the United States, cases peak in late summer ([@b0015]). U.S. cases peaked at 9862 in 2003, but approximately 2000 cases still occur annually ([@b0010]).

Sandfly-borne illnesses {#s0040}
-----------------------

### Leishmaniasis {#s0045}

The term "leishmaniasis" encompasses a variety of acute and chronic infections caused by several protozoa in the genus *Leishmania* and transmitted by phlebotomine sandflies. Cutaneous leishmaniasis is the most common form of the disease worldwide, but visceral disease (mainly found in the Old World) is the most virulent type. Cutaneous diseases manifests with nonhealing ulcers, usually on exposed surfaces of the head, neck, forearms, and hands ([Fig. 2](#f0010){ref-type="fig"} ).Fig. 2Cutaneous Leishmaniasis: Classic Chiclero's ulcer on the ear, caused by *Leishmania mexicana*.

Temperature and humidity influence sandfly survival and reproduction ([@b0295]). In the last several decades, rates of autochthonous cutaneous leishmaniasis in new areas have increased as environmental conditions become more favorable. In southern Europe, leishmaniasis case numbers are increasing as the sandfly's geographic range expands northward ([@b0240]). In one series of cases diagnosed in Texas from 2007 to 2017, 59% of cutaneous leishmaniasis cases occurred in patients with no travel outside the United States in the prior decade, representing a shift away from mostly travel-related leishmaniasis in the United States ([@b0255]).

Tick-borne illnesses {#s0050}
--------------------

### Lyme disease {#s0055}

Lyme disease is a bacterial infection caused by several spirochetes, mainly *Borrelia burgdorferi and Borrelia azfeli* ([@b0385]). It is transmitted only by *Ixodes* ticks: *Ixodes scapularis* in eastern/central North America, *Ixodes pacificus* along North America's West Coast, and *Ixodes ricinus* in Europe ([@b0385]). Important animal reservoirs include small mammals (e.g., mice, voles) and birds. Whitetail deer, which can support huge numbers of ticks, have an important role in maintaining tick populations ([@b0385]). Lyme disease manifests in three clinical stages, all with cutaneous manifestations, including localized erythema migrans (stage 1; [Fig. 3](#f0015){ref-type="fig"} A and B), disseminated erythema migrans (stage 2; [Fig. 3](#f0015){ref-type="fig"}C), and acrodermatitis chronica atrophicans and borrelial lymphocytoma (stage 3; both unique to Europe; [@b0385]).Fig. 3Lyme disease. Clinical stages of Lyme disease. (A, B) Localized erythema migrans (stage 1), which may lack the classic bullseye appearance (C) Multiple red patches of disseminated Lyme disease, also called secondary erythema migrans (stage 2).

Lyme disease occurs at temperate latitudes and only in the Northern hemisphere. Disease risk has been linked to warm winters, high summer temperatures, and relatively low interseasonal temperature variation ([@b0125]). The overall Lyme disease case count is increasing; moreover, its geographic range is expanding northward in both North America and Europe ([@b0190]) and will likely continue doing so due to the consequences of climate change on tick and reservoir populations ([@b0350], [@b0375]).

Rocky Mountain spotted fever {#s0060}
----------------------------

Rocky Mountain spotted fever (RMSF) is a life-threatening condition caused by *Rickettsia rickettsii,* transmitted by American dog ticks (*Dermacentor variabilis*) and Rocky Mountain wood ticks (*Dermacentor andersoni*). Recently, an unrelated tick, the brown dog tick (*Rhipicephalus sanguineus*), was confirmed as a vector in eastern Arizona, discontinuous with areas of *Dermacentor*-borne RMSF ([@b0115], [@b0290], [@b0410]). Clinical manifestations include flu-like symptoms with high fever, severe headache, malaise, and an acral, macular, erythematous rash that becomes petechial ([@b0290]). Early recognition is essential; diagnostic and treatment delays are associated with high mortality ([@b0290]).

The incidence of RMSF has increased steadily over the past 20 years ([@b0070]). Although disease reporting practices and improved physician awareness are contributing factors ([@b0305]), climate change may also play a role. Incidence is influenced by humidity and temperature, which affect the ranges of ticks and reservoirs and the amount of skin humans expose ([@b0340]). RMSF has its highest incidence in June and July, when adult *Dermacentor* are the most active ([@b0070]). Transmission via *R. sanguineus* also increases with warmer temperatures ([@b0315]).

The geographic range of RMSF is expanding in latitude and altitude ([@b0340]). Given the severity of untreated RMSF, dermatologists should be aware that RMSF may appear in previously nonendemic areas.

### Chagas disease {#s0065}

Chagas disease (CD) is caused by the protozoan *Trypanosoma cruzi*, transmitted to humans through bites by triatomine insects (*Triatoma, Panstrongylus, Rhodnius*; [@b0325]). Acute phase symptoms include fever, inoculation site inflammation, unilateral eyelid edema (Romaña sign), lymphadenopathy, and hepatosplenomegaly*.* This phase lasts 4 to 8 weeks and resolves spontaneously*.* Approximately 30% to 40% later develop visceral involvement, which can cause substantial morbidity and death ([@b0325]).

Triatomids are climate-sensitive insects. To avoid dehydration, they feed more often during times of high temperature (\>30 °C) and low humidity. Higher temperatures are associated with shorter life cycles ([@b0055]) and faster parasite maturation ([@b0020]).

Historically, CD has been endemic to rural Latin America, where poor housing conditions favor vector infestation. Most persons diagnosed in the United States acquired their infections in Latin America ([@b0265]). However, CD's geographic range may be expanding. In the United States, 28 autochthonous cases were reported from 1955 to 2015, but \>75% of these cases were after 2011 ([@b0040], [@b0265]). Since 2015, several additional autochthonous U.S. cases have been reported ([@b0035], [@b0155], [@b0170], [@b0180], [@b0415], [@b0455]). In the United States, local transmission is typically sylvatic (related to outdoor exposures) rather than domestic (from infested human dwellings; [@b0415]). Models of future distribution predict further poleward expansion ([@b0135]).

Climate-sensitive infectious diseases and extreme weather events {#s0070}
================================================================

Many microorganisms have distinct geographic distributions based on the ecological niches of microbes, vectors, nonhuman reservoirs, and human populations. Climate and weather patterns generally and temperature patterns specifically are among the most important ecological variables that define distributions across latitude and altitude. Human populations living outside the historical thermal boundaries of particular microbes may not have been exposed to these organisms. Changes in global temperature patterns therefore expose new and vulnerable populations to unfamiliar infectious diseases.

Moreover, infectious disease outbreaks often cluster around EWEs, which are increasingly common because of climate change. For example, drought-associated water scarcity impairs personal and public sanitation and may lead to exposure to contaminated water. Conversely, severe flooding damages infrastructure, which can compromise water supply safety and expose humans to water-borne pathogens ([@b0030], [@b0260]). Several outbreaks of infectious diseases, including hantavirus infection (Four Corners region of the southwestern United States) in the early 1990s ([@b0460]), cryptosporidiosis (Milwaukee, Wisconsin, 1993; [@b0195]), and malaria (East Africa; [@b0045], [@b0200], [@b0215], [@b0225]) occurred after severe flooding. Given the skin barrier's protective role, skin disease is especially common after flooding ([@b0365]). Below, we review specific EWE-associated infections with cutaneous manifestations.

Coccidioidomycosis {#s0075}
------------------

Coccidioidomycosis, or valley fever, is a systemic mycosis caused by the dimorphic organisms *Coccidioides immitis* and *Coccidioides posadasii*, which are endemic to arid regions of the Americas. Their confined geographic range reflects climate sensitivity. Their spores, found in soil approximately 10 cm below the surface, require moist periods to germinate, followed by dry spells to aerosolize ([@b0245], [@b0300]). Precipitation and wind are primary contributors to aerosolization. During heat waves, high temperatures deplete soil biota, reducing competition against *Coccidioides* ([@b0230], [@b0235]). Up to 50% of people living in endemic areas have been exposed to some form of *Coccidioides*, mainly via spore inhalation (rarely via cutaneous inoculation), but most never display symptoms ([@b0245]). Approximately 40% of infected people are symptomatic, and only 1% develop disseminated disease ([@b0380]). Transplant recipients, certain ethnic groups (e.g., Filipino-Americans), and patients with diabetes, malignancy, and HIV experience higher mortality ([@b0380]).

In the last 2 decades, the incidence of coccidioidomycosis has increased steadily for several reasons. Better diagnostic tests improve case detection, and regional population growth increases the size of vulnerable populations. Climate change leads to edaphic (soil-related) changes that permit marked expansion of the fungus' geographic range ([@b0095]). Spores have now been identified far north of the warm, arid Southwest, including Oregon ([@b0175]). Since 2010, at least 16 autochthonous cases have occurred in south-central Washington State ([@b0440]). Heavy rainfall in 2016 after prolonged drought in California was associated with increased cutaneous coccidioidomycosis incidence ([@b0105], [@b0370]). More recently, California's wildfires have been linked to an increased risk for coccidioidomycosis ([@b0280]).

Vibrio *species* {#s0080}
----------------

*Vibrio vulnificus* is a gram-negative bacterium transmitted by exposure to marine and brackish waters ([@b0310]). Typical clinical manifestations include bullous hemorrhagic cellulitis of the distal extremities ([@b0310]). The risk for cutaneous *Vibrio* infections increases after coastal flooding, as seen after Hurricane Katrina ([@b0080]). The worldwide environmental suitability for all pathogenic *Vibrio* species has steadily increased for several decades, particularly in the northern regions ([@b0445]), and cases are now seen along the Northern European coastline ([@b0025], [@b0185], [@b0425]).

Hand, foot, and mouth disease {#s0085}
-----------------------------

Hand, foot, and mouth disease (HFMD) is caused by various human enteroviruses. The condition typically affects children \<5 years old and manifests with erythematous papules and vesicles distributed acrally and intraorally ([Fig. 4](#f0020){ref-type="fig"} A-C). Rarely, severe systemic manifestations occur. Onychomadesis may develop ([Fig. 4](#f0020){ref-type="fig"}D). Enteroviruses are sensitive to temperature and humidity ([@b0100]). Climate change may have a role in HFMD epidemiology. In the past 30 years, HFMD has become a substantial public health burden in southeast Asia, where large, frequent, and virulent outbreaks have killed thousands of children ([@b0100]).Fig. 4Hand, foot, and mouth disease (HFMD) (A) Classic acral papules and vesicles in a patient with HFMD. (B) Papules and vesicles overlying the knee in a patient with HFMD. (C) Diffuse eczema coxsackium. (D) Onychomadesis following HFMD.

Future climate-sensitive microorganisms {#s0090}
---------------------------------------

Higher temperatures pose the threat of new, previously unidentified infectious diseases emerging as a consequence of progressive microbe adaptation. For example, most fungal species fare poorly at human core temperatures, which are far above average ambient temperatures anywhere in the world. However, many fungi have the capacity to develop thermotolerance ([@b0065], [@b0110]), which may eventually enable them to defeat the human endothermy thermal barrier ([@b0060]). Likewise, viruses that currently pose no threat to humans might spillover to humans if they acquire the capacity to replicate at higher temperatures. Additionally, organisms (including those that cause tularemia and anthrax) that have been frozen in thawing arctic permafrost may emerge to cause a greater disease burden ([@b0430]).

Human migration and infectious disease {#s0095}
======================================

For millennia, humans have migrated for environmental, sociopolitical, and economic reasons. Climate change threatens already marginalized populations worldwide, especially in regions dependent on subsistence agriculture. Crop production is threatened by pests, pathogens, and EWEs. Globally, crop yields for staple products (e.g., maize, winter wheat, soybeans) have declined in concert with rising temperatures ([@b0445]). Furthermore, the number of undernourished persons worldwide has been increasing since 2014 due to impaired access to and affordability of food ([@b0445]). Undernutrition predisposes individuals to numerous infectious diseases (The Lancet Infectious [@b0400]).

When local environments are no longer salubrious, populations decline and humans migrate, often across international borders when home countries become inhospitable. Mass migration destabilizes health care infrastructure, weakening individual-based medical care and public health measures. This decreases access to health care, lowers vaccination rates, impairs food quality and quantity, limits clean water access, degrades hygiene, and leads to overcrowding. This further exposes migrants to communicable diseases associated with poverty, including tuberculosis, ectoparasite (scabies and lice) infestations, HIV infection, and diarrheal diseases (many of which have dermatologic manifestations). Disease vectors and animal reservoirs are also affected---increased cases of cutaneous leishmaniasis have been linked to conflict and mass human migration in the Middle East ([@b0120], [@b0275]).

Conclusion {#s0100}
==========

Climate change alters the epidemiology of infectious diseases. VBDs may emerge or re-emerge within populations when climate variables change significantly. Climate change has driven increased environmental suitability for infectious diseases, from changes in climate, soils, forest cover, and land use. The current COVID-19 pandemic illustrates the consequences of failing to respond to an infectious disease outbreak swiftly and in a manner based on expert recommendations for containing disease spread. As the climate crisis unfolds, humanity will likely be challenged by additional opportunities to respond to novel or emerging infectious diseases. This warrants a concerted effort to develop enhanced surveillance methods to detect emerging and re-emerging infectious diseases, particularly those with no disease-specific vaccinations or treatments. Climate-based warning systems that identify regions at particular risk for disease outbreaks are under development. Targeted vector-control efforts, which have successfully addressed certain arbovirus outbreaks in the past, may be used successfully in areas with emerging diseases. Given the concern for antibiotic resistance and waning supplies of next-generation antibiotics, good stewardship of existing antibiotics and continued research to develop new antibiotics is essential. Dermatologists should understand that climate change will affect the burden and geographic distribution of infectious diseases, many of which have cutaneous signs and might be encountered during regular practice.
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